Scientists will be able to detect cancer earlier from blood samples after advances were made in detecting microRNA molecules using gold-plated nanoparticles.
UNSW researchers have discovered a new way to detect ultralow levels of microRNA in a blood sample which could make diagnosis of cancer and other illnesses quicker and more efficient.
The research team used nanoparticles to latch on to the targeted microRNAs (miRNAs) which enabled them to be easily extracted. One of the main benefits was that it was effective even when the miRNA was in minuscule amounts in the blood sample. Previously, a much larger sample was needed to extract similar amounts.
MicroRNAs are short RNA molecules that target some messenger RNAs (genetic material used to synthesise proteins) to prevent them from coding for a specific protein. Impaired miRNA activity has been linked with the formation of cancerous tumours as well as metastasis, the spread of cancer to other parts of the body.
In the paper published today in Nature Nanotechnology, the researchers reported modifying gold-coated magnetic nanoparticles (Au@MNPs) with DNA to match the miRNA they wanted to detect.
Scientia Professor Justin Gooding said the nanoparticles are, in effect, dispersible electrodes. When circulated through the blood they capture the miRNA before a magnet is used to recapture the nanoparticles with the newly attached microRNA.
“Now we get more of the microRNA because the dispersible electrodes capture nearly everything in the sample,” Professor Gooding said.
“Because the capture is so effective, we get higher sensitivities and can detect much lower limits.
“And since we bring them back to the electrode under a magnet, our response time is much faster.”
One of the advantages of being quicker is that it will cost less.
“It could be orders of magnitude cheaper. Our method takes 30 minutes compared with almost 12 hours for quantitative polymerase chain reaction,” Professor Gooding said.
Key to the new technology is not just the ability to detect lower concentrations of miRNA but the ability to detect a broad range of concentrations.
“This is really important to determine whether the levels of different microRNAs have increased or decreased,” Professor Gooding said.
“We can do this very quickly compared with the gold-standard nucleic acid amplification methods. And we can do it in unprocessed blood.
“What this means is the technology has the potential to determine the levels of microRNA just from a finger prick test.”
Professor Gooding said he would expect the technology to be available within three years, pending regulatory approvals.
The new diagnostic technique follows on the heels of a similar advance made by another UNSW research team exploring cancer detection in the blood.
In that study, published in Nature Communications, a team of medical researchers led by Professor Chris Heeschen developed a new way to detect early-stage cancer tumour cells in the blood using a malaria protein. This method, which targeted individual cancer cells found in a blood sample, also used a magnet to retrieve all the targeted cancer cells.
Professor Gooding believes the two methods, while working on very different scales, would be very complementary as tools to diagnose cancer.
“The malaria protein technology works by detecting cancer cells, rare cells in particular. These are found in the blood also and so are also compatible with the liquid biopsy concept,” he said.
“We are detecting small molecules found in the blood which could also identify the type of cancer, while they are looking for rare cells that are responsible for the spread of cancer. The two technologies could work very well together.”
Learn more: Blood-borne cancer detection receives gold-plated boost
The Latest on: Cancer blood test
[google_news title=”” keyword=”cancer blood test” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Cancer blood test
- Former state representative Basye stresses importance of yearly screenings after cancer diagnosison April 26, 2024 at 9:25 am
A former Mid-Missouri state representative who dropped out of a state Senate race this week after a second cancer diagnosis wants to make sure people get regular screenings.
- Patients died after errors by blood cancer serviceon April 24, 2024 at 10:23 pm
Four people have died following errors in Birmingham blood cancer services, the BBC can reveal. The latest deaths, in 2023 at University Hospitals Birmingham (UHB), have prompted an inquiry by The ...
- Company developing early cancer-detection tests to cut 20% of workforceon April 24, 2024 at 7:35 am
Early cancer-detection test maker that raised $254 million earlier this year now says it will cut more than 100 jobs — about 20% of its workforce — as it restructures ...
- New Test Detects Cancer In Minutes Using Just 1 Drop of Dried Bloodon April 24, 2024 at 6:04 am
A test devised in Shanghai could make cancer detection quicker, easier, and practical for multiple areas of the body at once. Using just one drop of dried blood, the test looks for biomarkers that ...
- Balancing hope and reality: The promise and peril of blood-based colorectal cancer screeningon April 24, 2024 at 1:30 am
A simple blood test to detect colorectal cancer sounds amazing. But unlike colonoscopy, a blood test can't remove precancerous polyps.
- AI-powered tool detects cancer in minutes with one drop of bloodon April 23, 2024 at 6:52 am
Scientists in China have developed a test that detects three types of cancers with just one spot of dried blood.
- Urine-based test detects head and neck canceron April 23, 2024 at 4:15 am
While the initial study focused on head and neck cancer, the team also analyzed urine samples of people with other cancers, such as breast and acute myeloid leukemia, and found that ultrashort ...
- Researchers developing new colon cancer tests amid rising caseson April 23, 2024 at 3:01 am
With more than 200,000 cases of colon cancer diagnosed across the country every year, researchers are working on new ways to detect the disease better.
- Detecting cancer in minutes possible with just a drop of dried blood and new test, study hintson April 22, 2024 at 9:19 am
Early tests suggest that a new tool that requires only a single drop of blood could detect three of the deadliest forms of cancer.
- New Urine Test for Prostate Cancer May Help Reduce Unnecessary Biopsieson April 22, 2024 at 4:19 am
A prostate cancer biomarker test that utilizes genes indicating high-grade prostate cancer appears highly accurate.
via Bing News